Savior Lifetec Corporation (TPEX:4167)
Taiwan
· Delayed Price · Currency is TWD 18.05
-0.15 (-0.82%)
At close: Dec 5, 2025
Savior Lifetec Revenue
Savior Lifetec had revenue of 282.48M TWD in the quarter ending September 30, 2025, a decrease of -15.03%. This brings the company's revenue in the last twelve months to 1.16B, down -7.92% year-over-year. In the year 2024, Savior Lifetec had annual revenue of 1.22B with 15.91% growth.
Revenue (ttm)
1.16B
Revenue Growth
-7.92%
P/S Ratio
4.84
Revenue / Employee
3.02M
Employees
384
Market Cap
5.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 167.05M | 15.91% |
| Dec 31, 2023 | 1.05B | -215.47M | -17.02% |
| Dec 31, 2022 | 1.27B | -478.04M | -27.41% |
| Dec 31, 2021 | 1.74B | -83.46M | -4.57% |
| Dec 31, 2020 | 1.83B | 508.55M | 38.56% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |
| Center Laboratories | 1.57B |
| Pegavision | 6.90B |